BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38142122)

  • 21. Role of COL6A2 in malignant progression and temozolomide resistance of glioma.
    Hong X; Zhang J; Zou J; Ouyang J; Xiao B; Wang P; Peng X
    Cell Signal; 2023 Feb; 102():110560. PubMed ID: 36521657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
    Feng F; Zhao Z; Cai X; Heng X; Ma X
    Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells.
    Wang F; Zhang P; Yang L; Yu X; Ye X; Yang J; Qian C; Zhang X; Cui YH; Bian XW
    Am J Transl Res; 2015; 7(3):607-15. PubMed ID: 26045899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glioma stem cell invasion through regulation of the interconnected ERK, integrin α6 and N-cadherin signaling pathway.
    Velpula KK; Rehman AA; Chelluboina B; Dasari VR; Gondi CS; Rao JS; Veeravalli KK
    Cell Signal; 2012 Nov; 24(11):2076-84. PubMed ID: 22789454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
    Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.
    Yu M; Xue Y; Zheng J; Liu X; Yu H; Liu L; Li Z; Liu Y
    Mol Cancer; 2017 Jun; 16(1):110. PubMed ID: 28651608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B7-H3 Regulates Glioma Growth and Cell Invasion Through a JAK2/STAT3/Slug-Dependent Signaling Pathway.
    Zhong C; Tao B; Chen Y; Guo Z; Yang X; Peng L; Xia X; Chen L
    Onco Targets Ther; 2020; 13():2215-2224. PubMed ID: 32210587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells.
    Han D; Yu T; Dong N; Wang B; Sun F; Jiang D
    J Exp Clin Cancer Res; 2019 Jul; 38(1):289. PubMed ID: 31277685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-128 inhibits EMT of human osteosarcoma cells by directly targeting integrin α2.
    Liu X; Liang Z; Gao K; Li H; Zhao G; Wang S; Fang J
    Tumour Biol; 2016 Jun; 37(6):7951-7. PubMed ID: 26700675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LASS2 impairs proliferation of glioma stem cells and migration and invasion of glioma cells mainly via inhibition of EMT and apoptosis promotion.
    Zhao WJ; Fan YP; Ou GY; Qiao XY
    J Cancer; 2022; 13(7):2281-2292. PubMed ID: 35517425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
    Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
    Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
    Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
    J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs.
    de la Rocha AMA; González-Huarriz M; Guruceaga E; Mihelson N; Tejada-Solís S; Díez-Valle R; Martínez-Vélez N; Fueyo J; Gomez-Manzano C; Alonso MM; Laterra J; López-Bertoni H
    Arch Clin Biomed Res; 2020; 4(3):221-238. PubMed ID: 32905473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
    Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R
    BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACYP2 contributes to malignant progression of glioma through promoting Ca
    Li M; Ruan B; Wei J; Yang Q; Chen M; Ji M; Hou P
    J Exp Clin Cancer Res; 2020 Jun; 39(1):106. PubMed ID: 32517717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
    Chen Z; Wang H; Zhang Z; Xu J; Qi Y; Xue H; Gao Z; Zhao R; Wang S; Zhang S; Qiu W; Guo X; Li G
    J Exp Clin Cancer Res; 2021 Jan; 40(1):20. PubMed ID: 33413577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of TEAD4 correlates with poor prognosis of glioma and promotes cell invasion.
    Xu A; Wang X; Zeng Y; Zhou M; Yi R; Wu Z; Lin J; Song Y
    Int J Clin Exp Pathol; 2018; 11(10):4827-4835. PubMed ID: 31949557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
    Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
    Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SRSF1/circATP5B/miR-185-5p/HOXB5 feedback loop regulates the proliferation of glioma stem cells via the IL6-mediated JAK2/STAT3 signaling pathway.
    Zhao J; Jiang Y; Zhang H; Zhou J; Chen L; Li H; Xu J; Zhang G; Jing Z
    J Exp Clin Cancer Res; 2021 Apr; 40(1):134. PubMed ID: 33858489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.